Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $151.00
  • Support level
    $135.14
  • Resistance level
    N/A
  • Beta
    0.4
  • RSI (14-day)
    70.7
  • GILD is one of this month's top performers with a return of 13.4 percent, beating 90 percent of stocks in the S&P-100.
  • Up 3.7 percent, GILD is one of this week's biggest gainers.
  • Volatility is forecast to fall over the next month.
  • GILD is above its 200-day moving average, providing a measure of support for long positions.
  • With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
  • Price broke above prior resistance level - a short-term bullish signal.

52-week range

52-week low 52-week high Price as % of range
$110.56 $155.80 90.9%

Moving averages

200 day 50 day 20 day 10 day
$134.36 $136.60 $144.35 $148.62

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    7.4%
  • In the next month
    14.9%
  • In the next year
    52.8%

Volatility estimates (annualized standard deviations)

Period Value
Historical (5 year) 24.4%
Last month 26.0%
Current estimate 27.3%
Next month forecast 26.4%